Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | YTHDC1 | Q96MU7 | 3/20 | 0.31 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10280149 | 0.74 | TRPA1 (0.36) | TRPA1RXFP1YTHDC1P2RY1 | |
| SCHEMBL19036405 | 0.71 | TRPA1 (0.34) | TRPA1RXFP1YTHDC1P2RY1 | |
| SCHEMBL27535381 | 0.64 | PDE4A (0.37) | TRPA1YTHDC1 | |
| SCHEMBL20161661 | 0.63 | TRPA1 (0.35) | TRPA1RXFP1 | |
| SCHEMBL19036512 | 0.63 | P2RY1 (0.37) | YTHDC1P2RY1 | |
| SCHEMBL15384376 | 0.61 | TRPA1 (0.33) | TRPA1RXFP1 | |
| SCHEMBL13384290 | 0.60 | TRPA1 (0.36) | TRPA1RXFP1 | |
| SCHEMBL1178676 | 0.60 | CYP19A1 (0.39) | TRPA1 | |
| SCHEMBL19036600 | 0.59 | YTHDC1 (0.37) | YTHDC1P2RY1 | |
| SCHEMBL18256648 | 0.59 | YTHDC1 (0.40) | YTHDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108614-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | HYDRA BIOSCIENCES, INC. | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108614-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | ELANE, CASP3, MMP8 | TRPA1 123/4885RXFP1 3119/4885YTHDC1 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.